Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.500 | None | 0.943 | 17 | 14 | 1996 | 2020 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.160 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.500 | None | 0.984 | 17 | 7 | 2001 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.100 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 16 | 22 | 2007 | 2019 | |||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 16 | 18 | 2006 | 2020 | ||||||||
|
cancer susceptibility 16 | 0.780 | 0.308 |
|
disease | 0.200 | None | 1.000 | 16 | 4 | 2007 | 2020 | |||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 16 | 7 | 1997 | 2020 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 16 | 10 | 2002 | 2020 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.130 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.170 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.200 | None | 0.903 | 14 | 8 | 2007 | 2020 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 14 | 7 | 2007 | 2019 |